Literature DB >> 27702426

Burkholderia pseudomallei resistance to antibiotics in biofilm-induced conditions is related to efflux pumps.

Nopphasul Sirijant1,2, Rasana W Sermswan2,3, Surasakdi Wongratanacheewin1,2.   

Abstract

Burkholderia pseudomallei, the causative agent of melioidosis, has been found to increase its resistance to antibiotics when growing as a biofilm. The resistance is related to several mechanisms. One of the possible mechanisms is the efflux pump. Using bioinformatics analysis, it was found that BPSL1661, BPSL1664 and BPSL1665 were orthologous genes of the efflux transporter encoding genes for biofilm-related antibiotic resistance, PA1874-PA1877 genes in Pseudomonas aeruginosa strain PAO1. Expression of selected encoding genes for the efflux transporter system during biofilm formation were investigated. Real-time reverse transcriptase PCR expression of amrB, cytoplasmic membrane protein of AmrAB-OprA efflux transporter encoding gene, was slightly increased, while BPSL1665 was significantly increased during growth of bacteria in biofilm formation. Minimum biofilm inhibition concentration and minimum biofilm eradication concentration (MBEC) of ceftazidime (CTZ), doxycycline (DOX) and imipenem were found to be 2- to 1024-times increased when compared to their MICs for of planktonic cells. Inhibition of the efflux transporter by adding phenylalanine arginine β-napthylamide (PAβN), a universal efflux inhibitor, decreased 2 to 16 times as much as MBEC in B. pseudomallei biofilms with CTZ and DOX. When the intracellular accumulation of antibiotics was tested to reveal the pump inhibition, only the concentrations of CTZ and DOX increased in PAβN treated biofilm. Taken together, these results indicated that BPSL1665, a putative precursor of the efflux pump gene, might be related to the adaptation of B. pseudomallei in biofilm conditions. Inhibition of efflux pumps may lead to a decrease of resistance to CTZ and DOX in biofilm cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27702426     DOI: 10.1099/jmm.0.000358

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

1.  Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei.

Authors:  Jessica R Webb; Erin P Price; Bart J Currie; Derek S Sarovich
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

Review 2.  Melioidosis.

Authors:  W Joost Wiersinga; Harjeet S Virk; Alfredo G Torres; Bart J Currie; Sharon J Peacock; David A B Dance; Direk Limmathurotsakul
Journal:  Nat Rev Dis Primers       Date:  2018-02-01       Impact factor: 52.329

3.  Biofilm formation in Acinetobacter baumannii was inhibited by PAβN while it had no association with antibiotic resistance.

Authors:  Lihua Chen; Haixia Li; Haichu Wen; Binyu Zhao; Yujia Niu; Qianqian Mo; Yong Wu
Journal:  Microbiologyopen       Date:  2020-07-22       Impact factor: 3.139

4.  Burkholderia collagen-like protein 8, Bucl8, is a unique outer membrane component of a putative tetrapartite efflux pump in Burkholderia pseudomallei and Burkholderia mallei.

Authors:  Megan E Grund; Soo J Choi; Dudley H McNitt; Mariette Barbier; Gangqing Hu; P Rocco LaSala; Christopher K Cote; Rita Berisio; Slawomir Lukomski
Journal:  PLoS One       Date:  2020-11-23       Impact factor: 3.240

5.  Transcriptomics Analysis Uncovers Transient Ceftazidime Tolerance in Burkholderia Biofilms.

Authors:  Supaksorn Chattagul; Mohd M Khan; Alison J Scott; Aleksandra Nita-Lazar; Robert K Ernst; David R Goodlett; Rasana W Sermswan
Journal:  ACS Infect Dis       Date:  2021-06-17       Impact factor: 5.578

6.  GC-072: A Novel Therapeutic Candidate for Oral Treatment of Melioidosis and Infections Caused by Select Biothreat Pathogens.

Authors:  Jeffry D Shearer; Michelle L Saylor; Christine M Butler; Anthony M Treston; Henry S Heine; Sunisa Chirakul; Herbert P Schweizer; Arnold Louie; George L Drusano; Steven D Zumbrun; Kelly L Warfield
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.